Merck stock overview after recent performance moves Merck (MRK) has drawn fresh investor attention after a mixed stretch in ...

Merck heads into Q1 with strong Keytruda demand but rising pressure from generics, vaccines slump, and deal costs persist.

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...

Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Performing Dow Stocks So Far in 2026.

Merck (MRK) closed the most recent trading day at $111.90, moving -2.37% from the previous trading session. This move lagged the S&P 500's daily gain of 0.8%. Meanwhile, the Dow experienced a drop of ...

Merck (MRK) stock is in focus as the company and Eisai (ESALF) announce a setback in a late-stage trial for two ...

Sandisk, Marvell, and AMD. Please visit Jim Cramer’s 12 Stock Calls: GE Vernova, Arm, and Vertiv, if you’d like to see the ...

MRK is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of MRK shares has decreased $0.20 since the market last closed. This is a 0.18% ...

Merck (MRK) stock climbed 3% after FDA granted priority review for KEYTRUDA bladder cancer treatment combination, with ...

Merck (MRK)’s stock surged by 41% in the last six months, driven not only by a modest revenue increase but also by a significant profit jump and heightened investor confidence. The factors behind this ...

Merck (MRK) stock is in focus as the company and its rivals are seeking agreements for a cancer drug from Inhibrx Biosciences ...